STUDIO SULLA TOLLERABILITA ED EFFICACIA DEL BUDESONIDE TOPICO NELLA TERAPIA DELLA DERMATITE ATOPICA IN ETA PEDIATRICA

Translated title of the contribution: Tolerability and efficacy of topical budesonide in the treatment of atopic dermatitis in pediatric age

C. Gelmetti, R. Grimalt, G. Del Campo, R. Caputo

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The use of topical corticosteroids in the treatment of atopic dermatitis is still the first choice in the majority of patients. In this study the efficacy as well as local and systemic side effects of a recent topical non-alogenated steroid, budesonide cream 0.025%, have been compared to alclometasone dipropionate cream 0.1%, a drug which is appreciated for its activity and tolerability. Forty children, to whom the two drugs were given at random, were treated twice a day for two weeks. Budesonide proved to be effective and well tolerated in most of the children. Both efficacy and lack of side-effects can be compared with the control cream. The introduction of new corticosteroids demonstrates that the potency and the incidence of side-effects are no longer correlated. However the possibility of allergic reactions to this class of drug is an experienced event. This circumstance must be carefully considered, mostly in the treatment of children in which a possible sensitization would result more dangerous than in adults.

Original languageItalian
JournalGiornale Italiano di Dermatologia e Venereologia
Volume129
Issue number3
Publication statusPublished - 1994

Fingerprint

Budesonide
Atopic Dermatitis
Pediatrics
Adrenal Cortex Hormones
Pharmaceutical Preparations
Hypersensitivity
Therapeutics
Steroids
Incidence

ASJC Scopus subject areas

  • Dermatology

Cite this

STUDIO SULLA TOLLERABILITA ED EFFICACIA DEL BUDESONIDE TOPICO NELLA TERAPIA DELLA DERMATITE ATOPICA IN ETA PEDIATRICA. / Gelmetti, C.; Grimalt, R.; Del Campo, G.; Caputo, R.

In: Giornale Italiano di Dermatologia e Venereologia, Vol. 129, No. 3, 1994.

Research output: Contribution to journalArticle

@article{18f7c22e06fd41fb9180af2f9d1d3529,
title = "STUDIO SULLA TOLLERABILITA ED EFFICACIA DEL BUDESONIDE TOPICO NELLA TERAPIA DELLA DERMATITE ATOPICA IN ETA PEDIATRICA",
abstract = "The use of topical corticosteroids in the treatment of atopic dermatitis is still the first choice in the majority of patients. In this study the efficacy as well as local and systemic side effects of a recent topical non-alogenated steroid, budesonide cream 0.025{\%}, have been compared to alclometasone dipropionate cream 0.1{\%}, a drug which is appreciated for its activity and tolerability. Forty children, to whom the two drugs were given at random, were treated twice a day for two weeks. Budesonide proved to be effective and well tolerated in most of the children. Both efficacy and lack of side-effects can be compared with the control cream. The introduction of new corticosteroids demonstrates that the potency and the incidence of side-effects are no longer correlated. However the possibility of allergic reactions to this class of drug is an experienced event. This circumstance must be carefully considered, mostly in the treatment of children in which a possible sensitization would result more dangerous than in adults.",
keywords = "budesonide, corticosteroids, topical, dermatitis, atopic",
author = "C. Gelmetti and R. Grimalt and {Del Campo}, G. and R. Caputo",
year = "1994",
language = "Italian",
volume = "129",
journal = "Minerva dermatologica",
issn = "0392-0488",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "3",

}

TY - JOUR

T1 - STUDIO SULLA TOLLERABILITA ED EFFICACIA DEL BUDESONIDE TOPICO NELLA TERAPIA DELLA DERMATITE ATOPICA IN ETA PEDIATRICA

AU - Gelmetti, C.

AU - Grimalt, R.

AU - Del Campo, G.

AU - Caputo, R.

PY - 1994

Y1 - 1994

N2 - The use of topical corticosteroids in the treatment of atopic dermatitis is still the first choice in the majority of patients. In this study the efficacy as well as local and systemic side effects of a recent topical non-alogenated steroid, budesonide cream 0.025%, have been compared to alclometasone dipropionate cream 0.1%, a drug which is appreciated for its activity and tolerability. Forty children, to whom the two drugs were given at random, were treated twice a day for two weeks. Budesonide proved to be effective and well tolerated in most of the children. Both efficacy and lack of side-effects can be compared with the control cream. The introduction of new corticosteroids demonstrates that the potency and the incidence of side-effects are no longer correlated. However the possibility of allergic reactions to this class of drug is an experienced event. This circumstance must be carefully considered, mostly in the treatment of children in which a possible sensitization would result more dangerous than in adults.

AB - The use of topical corticosteroids in the treatment of atopic dermatitis is still the first choice in the majority of patients. In this study the efficacy as well as local and systemic side effects of a recent topical non-alogenated steroid, budesonide cream 0.025%, have been compared to alclometasone dipropionate cream 0.1%, a drug which is appreciated for its activity and tolerability. Forty children, to whom the two drugs were given at random, were treated twice a day for two weeks. Budesonide proved to be effective and well tolerated in most of the children. Both efficacy and lack of side-effects can be compared with the control cream. The introduction of new corticosteroids demonstrates that the potency and the incidence of side-effects are no longer correlated. However the possibility of allergic reactions to this class of drug is an experienced event. This circumstance must be carefully considered, mostly in the treatment of children in which a possible sensitization would result more dangerous than in adults.

KW - budesonide

KW - corticosteroids, topical

KW - dermatitis, atopic

UR - http://www.scopus.com/inward/record.url?scp=0028069951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028069951&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:0028069951

VL - 129

JO - Minerva dermatologica

JF - Minerva dermatologica

SN - 0392-0488

IS - 3

ER -